Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cryptococcus neoformans

被引:18
作者
Blackstock, R
Murphy, JW
机构
关键词
D O I
10.1128/IAI.65.10.4114-4121.1997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two isolates of Cryptococcus neoformans were identified as being widely divergent in pathogenic potential after intratracheal infection of mice, These isolates differed in their ability to upregulate capsule synthesis when grown under tissue culture conditions, and this property correlated with virulence. We postulated that differential capsule synthesis may cause differential stimulation of macrophages to produce products such as complement components. To test this hypothesis, heat-killed yeast cells were incubated with normal mouse peritoneal cells (PC) before the level of C3 secreted was determined, Cryptococcal stimulants were grown on mycological agar, which does not promote capsule synthesis, or in RPMI 1640 at 37 degrees C in an atmosphere of 5% CO2, which stimulates capsule synthesis, to determine the role that the capsule plays in the induction of C3 secretion, C3 levels were elevated in cultures containing cryptococci grown in RPMI 1640 at 37 degrees C in an atmosphere of 5% CO2, and the level of C3 detected was correlated with the amount of capsule expressed by the yeast cell stimulant. Nonencapsulated mutants of C. neoformans did not stimulate C3 secretion. Purified capsular polysaccharide (glucuronoxylomannan [GXM]) also stimulated the PC to secrete C3, Two signals were required before GXM stimulated C3 secretion. The second signal was identified as endotoxin present in small amounts (0.06 ng per mi) in tissue medium. Endotoxin may provide a priming stimulus for PC to express receptors or other cytokines needed for effective stimulation of C3, These experiments show that enhancement of C3 secretion by C. neoformans is due to GXM and is correlated with the virulence of the cryptococcal isolate.
引用
收藏
页码:4114 / 4121
页数:8
相关论文
共 47 条
[41]   PHAGOCYTOSIS OF CRYPTOCOCCUS-NEOFORMANS BY NORMAL AND THIOGLYCOLATE-ACTIVATED MACROPHAGES [J].
SWENSON, FJ ;
KOZEL, TR .
INFECTION AND IMMUNITY, 1978, 21 (03) :714-720
[42]  
Takabayashi T, 1996, J IMMUNOL, V156, P3455
[43]   CULTURE OF CRYPTOCOCCUS NEOFORMANS IN THE NON-ENCAPSULATED STATE [J].
TRIPP, C ;
RUIZ, A ;
BULMER, GS .
MYCOPATHOLOGIA, 1981, 76 (03) :129-131
[44]  
Tsuji RF, 1996, J IMMUNOL, V156, P4644
[45]   Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes [J].
Vecchiarelli, A ;
Retini, C ;
Monari, C ;
Tascini, C ;
Bistoni, F ;
Kozel, TR .
INFECTION AND IMMUNITY, 1996, 64 (07) :2846-2849
[46]   CRYPTOCOCCUS-NEOFORMANS MELANIN AND VIRULENCE - MECHANISM OF ACTION [J].
WANG, YL ;
AISEN, P ;
CASADEVALL, A .
INFECTION AND IMMUNITY, 1995, 63 (08) :3131-3136
[47]   PRODUCTION OF THE HEXITOL D-MANNITOL BY CRYPTOCOCCUS-NEOFORMANS INVITRO AND IN RABBITS WITH EXPERIMENTAL MENINGITIS [J].
WONG, B ;
PERFECT, JR ;
BEGGS, S ;
WRIGHT, KA .
INFECTION AND IMMUNITY, 1990, 58 (06) :1664-1670